Uveal Melanoma Brochure

In this brochure you may find a schematic representation of the most important topics about uveal melanoma: who is most affected, how it is diagnosed, preferential treatment option for cancer in the eye, surveillance and metastatic disease managing.

Click here to download the UMCURE 2020 Project’s brochure.

For Patients & Families

Find out more about the Research Consortium and be informed about Uveal Melanoma contact a UM CURE 2020 reference hospital, connect with other patients, find new clinical trials.

Learn more at our Video Library , where you can find explanatory videos and interviews.

For Researchers & Clinicians

Find out more about Research Consortium and who we are, learn about our research approach and the clinical implementation of our results.

News and Media

Does radiotherapy influence the results of genetic tests performed on UM biopsies? Loss of BAP1 expression leads to a suppression of the immune response to UM New advances in genetic tests for UM prognostication Uveal Melanoma Patients' Brochure The potential use of aqueous humor for risk stratification in UM

Events and Meetings

ARVO 2019 55th OOG Meeting 2019 ISOO 2019 EACR Conference – Defence is the Best Attack: Immuno-Oncology Breakthroughs AACR Annual Meeting 2019

Latest Publications

Uveal Melanoma: A European Network to Face the Many Challenges of a Rare Cancer Digital PCR-based T Cell Quantification Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma Treatment of uveal melanoma: where are we now? Recent breakthroughs in metastatic uveal melanoma: a cause for optimism? Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT).

List of Collaborators

‹ ›